Measuring and Reducing Microplastic Toxic Burden to Protect Heart Health
A 2024 New England Journal of Medicine study found microplastics embedded in arterial plaque were associated with higher rates of heart attack, stroke, and death — even after adjusting for traditional risk factors.
Microplastics are now being detected in liver, lung, and brain tissue. Exposure is established; the question is how to quantify and address it.
Intervention depends on total toxic burden. Our model is simple: measure, intervene, then re-measure to track progress.
EBOO (extracorporeal blood ozone oxidation) filters blood through a controlled ozone system to reduce circulating toxins. For higher-burden cases, therapeutic plasma exchange replaces the plasma fraction that carries many inflammatory proteins and lipid‑soluble toxins.
For patients focused on long-term resilience and disease prevention, this approach turns diffuse environmental exposure into measurable, actionable data.
Contact our clinic to schedule a toxic burden assessment and determine the most appropriate detox strategy for you.
